VIR
Vir Biotechnology, Inc.
Halal Rating :
See Details
Last Price
$10.38
Last updated:
Market Cap
$1.14b
7D Change
26.12%
1 Year Change
-59.29%
Company Overview
Industries
Exchange
NASDAQ
Next Earnings Date
Feb. 22, 2024
Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. The company is headquartered in San Francisco, California.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Dec. 31, 2023 | $16.79m | $155.37m | $20.74m | $239000.0 | 123.52% | 0.15% |
| Sept. 30, 2023 | $2.64m | $189.37m | $21.93m | - | 831.03% | 0.00% |
| June 30, 2023 | $3.8m | $218.98m | $23.02m | - | 606.16% | 0.00% |
Company Impact
Help us evaluate Vir Biotechnology, Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.